|
Volumn 51, Issue 7, 2012, Pages 502-507
|
[The efficacy and safety of continuous erythropoietin receptor activator in dialytic patients with chronic renal anemia: an open, randomized, controlled, multi-center trial].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR;
ERYTHROPOIETIN;
MACROGOL DERIVATIVE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CHRONIC KIDNEY FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
MIDDLE AGED;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
TREATMENT OUTCOME;
ADULT;
AGED;
ANEMIA;
ERYTHROPOIETIN;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
RENAL DIALYSIS;
TREATMENT OUTCOME;
|
EID: 84879267772
PISSN: 05781426
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|